Evidence map›Paper›PMID 35106677›Full record

ArticleNeurosurgical review2022

The role of imaging features and resection status in the survival outcome of sporadic optic pathway glioma children receiving different adjuvant treatments.

Zhi-Ming Liu, Chi-Hyi Liao, Xu An, Wen-Tao Zhou, Zhen-Yu Ma, Wei Liu, Yong-Ji Tian

Abstract read
PubMed Publisher
In one paragraph

Article in Neurosurgical review, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhi-Ming Liu *Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, No. 119, South 4th Ring Road, Fengtai District, Beijing, 100070, China.
Chi-Hyi Liao *Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, No. 119, South 4th Ring Road, Fengtai District, Beijing, 100070, China.
Xu AnDepartment of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, No. 119, South 4th Ring Road, Fengtai District, Beijing, 100070, China.
Wen-Tao ZhouDepartment of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, No. 119, South 4th Ring Road, Fengtai District, Beijing, 100070, China.
Zhen-Yu MaDepartment of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, No. 119, South 4th Ring Road, Fengtai District, Beijing, 100070, China.
Wei LiuDepartment of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, No. 119, South 4th Ring Road, Fengtai District, Beijing, 100070, China.
Yong-Ji TianDepartment of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, No. 119, South 4th Ring Road, Fengtai District, Beijing, 100070, China. tianyongji@bjtth.org.ORCID http://orcid.org/0000-0001-9915-8630
Capital Medical University · CN

Funding

Capital's Funds for Health Improvement and Research 2020-2-2047
6 · The paper itself

Abstract

Optic pathway glioma (OPG) is a rare brain tumor affecting children, with no standard treatment strategy. This study described the sporadic OPG survival outcomes after surgical treatment and analyzed the role of imaging features and resection status in children receiving different adjuvant treatments. This retrospective study included 165 OPG patients whose clinical information were obtained from the hospital record system. Tumor volume and residual tumor volume were calculated by delineating the lesion area. Kaplan-Meier method and Cox proportional hazards model were conducted to analyze the independent prognosis factor. A total of 165 patients were included in this study. Respectively, the 5-year overall survival (OS) and progression-free survival (PFS) were 87.58% and 77.87%. Residual tumor size and first adjuvant treatment (AT) after surgery were both associated with PFS. In patients with small-size residual tumors, there was no significant difference in PFS between the AT treatment groups. Moreover, age, exophytic cystic components, leptomeningeal metastases, and AT were associated with OS. In patients with exophytic cystic components and those with leptomeningeal metastases, there was no significant difference in OS. Our results revealed that OPG patients could avoid or defer AT by maximized resection. Age ≤ 2 years was a disadvantageous factor for OS. Patients with exophytic cystic components were more likely to benefit from primary surgery, and CT or RT was not beneficial for these patients. Patients with leptomeningeal metastases had a poor prognosis regardless of the treatment they received. Future prospective clinical studies are needed to develop more effective treatment regimens.

Indexed as

Brain NeoplasmsOptic Nerve GliomaChildChild, PreschoolDisease-Free SurvivalHumansNeoplasm, ResidualPrognosisRetrospective StudiesAdjuvant treatmentCystic componentsDebulking surgeryImagingOptic pathway glioma

Identifiers

PMID35106677
OpenAlexW4210760240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.